What Researchers Did
Researchers conducted a Cochrane review to compare the success, morbidity, patient satisfaction, and cost-effectiveness of dental implant treatment with and without hyperbaric oxygen therapy (HBO) in irradiated patients.
What They Found
Despite extensive searches across multiple electronic databases and attempts to identify unpublished trials, the researchers found no randomized controlled trials comparing hyperbaric oxygen therapy with no therapy for irradiated patients requiring dental implants. Consequently, no data on the success, morbidity, patient satisfaction, or cost-effectiveness of HBO in this context could be analyzed.
What This Means for Canadian Patients
Canadian patients who have undergone radiotherapy and require dental implants currently lack clear evidence regarding the benefits or risks of hyperbaric oxygen therapy to improve implant success. Decisions about HBO in this patient group should be made cautiously, considering the absence of robust clinical trial data.
Canadian Relevance
This review has no specific Canadian connection as it did not include Canadian-specific studies or authors.
Study Limitations
The main limitation of this review is the complete lack of identified randomized controlled trials, preventing any conclusive findings on the effectiveness of hyperbaric oxygen therapy for dental implants in irradiated patients.